Literature DB >> 22855660

Metabolic alkalosis, acute renal failure and epileptic seizures as unusual manifestations of an upside-down stomach.

Johannes Stephani1, Martin Wagner, Thomas Breining, Jochen Klaus, Jan-Hendrik Niess.   

Abstract

Upside-down stomach represents a critical and rare manifestation of hiatal hernias. Here we report on a 60-year-old male patient who was admitted to our hospital with epileptic seizures and dehydration. Laboratory tests revealed severe metabolic alkalosis (pH 7.56) with low potassium (2.7 mmol/l), hypochloremia (<60 mmol/l), increased hematocrit (53%) and high levels of serum creatinine (651 µmol/l). Based on a history of recurrent vomiting, gastroscopy and computed tomography were performed. Both diagnostics showed an upside-down stomach with signs of incarceration. Upon infusion of sodium chloride 0.9%, acid-base state, electrolyte balance and renal function became improved. Subsequently, the patient was referred to the department of surgery for hiatoplasty with fundoplication. This case report highlights severe metabolic and neurological disorders as unusual and life-threatening complications of an upside-down stomach.

Entities:  

Keywords:  Epileptic seizures; Hiatal hernia; Metabolic alkalosis; Renal failure; Upside-down stomach

Year:  2012        PMID: 22855660      PMCID: PMC3398073          DOI: 10.1159/000341509

Source DB:  PubMed          Journal:  Case Rep Gastroenterol        ISSN: 1662-0631


Introduction

Hiatal hernias represent a frequent gastrointestinal disorder caused by herniation of abdominal organs through the esophageal hiatus. The etiology of hiatal hernias is based on three mechanisms: widening of the diaphragmatic hiatus, pulling up of the stomach by esophageal shortening and pushing up of the stomach by increased intraabdominal pressure [1]. Accordingly, there is a high prevalence of hiatal hernias in power athletes and obese people [2, 3]. Moreover, familial clusters of hiatal hernias have been described, and the prevalence of hiatal hernias is increased in western populations as shown by a comparison of English (49%) and Singaporean (4%) patients with dyspepsia who underwent upper endoscopy [4, 5]. Four types of hiatal hernias can be distinguished [6]. Type I or sliding hiatal hernia is the most common type (85–95%). It is characterized by a partial herniation of the stomach associated with insufficient closure of the esophageal orifice due to a widening of the muscular hiatal tunnel. Type II, III and IV hiatal hernias are variants of a paraesophageal hernia. In opposition to type I hernia, the gastroesophageal junction of type II hernia remains fixed to the preaortic fascia and the median arcuate ligament. However, a defect in the phrenoesophageal membrane allows gastric herniation, and a continuous enlargement of type II hernia leads to intrathoracic placement of the stomach with the pylorus juxtaposed to the gastric cardia, also referred to as upside-down stomach. Type III hernia consists of type I and II elements, and type IV hernia is caused by a large defect in the phrenoesophageal membrane which allows herniation of other abdominal organs such as colon, spleen, pancreas and small intestine. Type I hiatal hernias are often asymptomatic. The most common symptom is heartburn caused by gastroesophageal reflux disease, which can be successfully treated with proton pump inhibitors [7]. By contrast, patients with paraesophageal hernias are at risk of complications such as incarceration, bleeding, strangulation or perforation. Therefore, surgery is recommended for symptomatic paraesophageal hernias [8]. Here we report on the unusual manifestation of an upside-down stomach. We describe in detail clinical findings, diagnostic steps and treatment strategies.

Case Report

A 60-year-old male patient was admitted to our hospital with epileptic seizures and dehydration. Clinical examination revealed a delirious patient with skin and mucosal dryness. Family members reported on recurrent vomiting. There was no regular medication taken by the patient. Magnetic resonance imaging excluded cerebral bleeding and ischemia. Laboratory tests showed an elevated serum pH (7.56), increased levels of bicarbonate (67.5 mmol/l) and unmeasurable base excess representing a metabolic alkalosis which was partially compensated by increased carbon dioxide (76 mm Hg) (table ). In addition, potassium (2.7 mmol/l) and chloride (<60 mmol/l) were reduced whereas sodium was normal (143 mmol/l). Moreover, elevated levels of hematocrit (53%) and creatinine (651 µmol/l) confirmed massive dehydration (table 1). To rule out differential diagnosis, serum concentrations of adrenocorticotropic hormone (ACTH), cortisol, renin and aldosterone were determined. While levels of cortisol (84.3 µg/dl), renin (83.6 pg/ml) and aldosterone (289 pg/ml) were elevated, ACTH (32.5 pg/ml) as well as the aldosterone/renin ratio (3.46) were not altered (table ). This constellation points to an activation of the sympathetic nervous system but does not support endocrinological disorders such as Cushing or Conn syndrome.
Table 1

Laboratory test results from venous blood

Normal valuesDay of admissionDay after admission
pH7.37–7.457.567.43
pCO232–46 mm Hg7682
pO271–104 mm Hg4559
Bicarbonate21–26 mmol/l67.554.1
Base excess–2.0–3.0NM24.1
Sodium135–145 mmol/l143141
Potassium3.5–4.5 mmol/l2.73.1
Chloride95–105 mmol/l<6082
Calcium2.1–2.6 mmol/l2.4ND
Magnesium0.66–0.99 mmol/l1.24ND
Creatinine62–106 µmol/l651554
Creatine kinase20–200 U/l1,197602
Hematocrit42–50%53%44%

Values from venous blood showed metabolic alkalosis (pH 7.56) with partial respiratory compensation (pCO2 76 mm Hg) as well as reduced levels of potassium (2.7 mmol/l) and chloride (<60 mmol/l) indicating loss of gastric acid. High levels of creatinine (651 µmol/l) and hematocrit (53%) reflected severe dehydration with acute renal failure. Increased levels of creatine kinase (1,197 U/l) were caused by epileptic seizures. Numbers marked bold highlight pathological values. NM = Not measurable; ND = not determined.

Abdominal ultrasound excluded postrenal failure, and an enlarged stomach indicated gastric outlet obstruction (fig. ). Based on this finding and on persisting dysphagia, gastroscopy was performed. Here 3 l of fluid were removed from the stomach and esophagus. Thereupon we observed a large hiatal hernia with an intrathoracic pylorus and multiple mucosal hemorrhages (fig. ). This result was confirmed by computed tomography, which showed an upside-down stomach in the posterior mediastinum and a hiatal hernia 3.5 cm in diameter (fig. ). Moreover the stomach was surrounded by a fluid fringe indicating incipient incarceration. As an additional finding, pulmonary infiltrates in the right inferior lobe indicated aspiration pneumonia. Taken together, we diagnosed severe hypochloremic metabolic alkalosis and acute prerenal failure which were caused by recurrent vomiting due to an upside-down stomach and triggered epileptic seizures. Intravenous application of sodium chloride 0.9% and potassium improved acid-base state, electrolyte homeostasis and kidney function. Subsequently, the patient was referred to the department of surgery and hiatoplasty with fundoplication was successfully performed.

Conclusions

Upside-down stomach represents a critical stage of type II paraesophageal hernia. About one third of patients with a type II hernia develop complications such as intrathoracic incarceration, bleeding, strangulation or perforation [8]. Accordingly, the most common symptoms include thoracoabdominal pain, heartburn, dysphagia, vomiting and signs of gastrointestinal bleeding, but also dyspnea, cough or precordial oppression can result from intrathoracic squeezing effects of paraesophageal herniation [9]. In addition to such common symptoms, the patient described above developed severe systemic disorders including metabolic alkalosis, acute renal failure and epileptic seizures. Recurrent vomiting due to an upside-down stomach resulted in the loss of large amounts of gastric acid which caused metabolic alkalosis and acute prerenal failure. In addition, metabolic imbalance triggered epileptic seizures. As a differential diagnosis the milk-alkali syndrome, gastric hypersecretion or a large excess of adrenocortical hormones need to be considered. The milk-alkali syndrome is caused by a high intake of calcium carbonate triggering hypercalcemia, metabolic alkalosis and acute renal failure [10]. The latter two effects can also occur in patients suffering from short bowel syndrome with gastric hypersecretion [11]. Cushing and Conn syndrome both enhance renal acid excretion and thereby induce metabolic alkalosis. However, the clinical course of disease, the absence of hypertension, hyperglycemia or calcium dysregulation as well as normal levels of ACTH and aldosterone/renin ratio excluded these differential diagnoses. Taken together, this case report highlights upside-down stomach as a possible cause of severe systemic disorders including metabolic alkalosis, acute renal failure and epileptic seizures. Furthermore, the course of disease confirms that surgical treatment of symptomatic type II hiatal hernias should be performed to prevent life-threatening complications.

Disclosure Statement

The authors declare no financial or nonfinancial competing interests.
Table 2

Analysis of hormones regulating the acid-base state

Normal valuesDay after admission
ACTH7.2–63.3 pg/ml32.5
Cortisol2.3–19.4 µg/dl84.3
Aldosterone10–160 pg/ml289
Renin2.9–27.6 pg/ml83.6
Aldosterone/renin ratio<50 (pg/ml)/(pg/ml)3.46

Analysis of ACTH, cortisol, renin and aldosterone revealed no evidence for hyperaldosteronism (Conn syndrome) or ACTH-dependent hypercortisolism (Cushing syndrome). Elevated levels of cortisol (84.3 µg/dl), renin (83.6 pg/ml) and aldosterone (289 pg/ml) were most probably caused by activation of the sympathetic nervous system in a critically ill patient. Numbers marked bold highlight pathological values.

  11 in total

Review 1.  Surgical treatment of gastroesophageal reflux disease.

Authors:  S Horgan; C A Pellegrini
Journal:  Surg Clin North Am       Date:  1997-10       Impact factor: 2.741

2.  Sliding hiatus hernias in identical twins.

Authors:  J J Sidd; J I Gilliam; B P Bushueff
Journal:  Br J Radiol       Date:  1966-09       Impact factor: 3.039

3.  Pressure-overload-induced sliding hiatal hernia in power athletes.

Authors:  A B Smith; R D Dickerman; C S McGuire; J W East; W J McConathy; H F Pearson
Journal:  J Clin Gastroenterol       Date:  1999-06       Impact factor: 3.062

4.  Different prevalences of reflux oesophagitis and hiatus hernia among dyspeptic patients in England and Singapore.

Authors:  J Y Kang; K Y Ho
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-08       Impact factor: 2.566

5.  Severe metabolic alkalosis and recurrent acute on chronic kidney injury in a patient with Crohn's disease.

Authors:  Johannes Jacobi; Susanne Schnellhardt; Mirian Opgenoorth; Kerstin U Amann; Axel Küttner; Axel Schmid; Kai-Uwe Eckardt; Karl F Hilgers
Journal:  BMC Nephrol       Date:  2010-04-18       Impact factor: 2.388

6.  Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects.

Authors:  P L Peghini; P O Katz; D O Castell
Journal:  Gastroenterology       Date:  1998-12       Impact factor: 22.682

Review 7.  The role of the hiatus hernia in gastro-oesophageal reflux disease.

Authors:  C Gordon; J Y Kang; P J Neild; J D Maxwell
Journal:  Aliment Pharmacol Ther       Date:  2004-10-01       Impact factor: 8.171

Review 8.  Approaches to the diagnosis and grading of hiatal hernia.

Authors:  Peter J Kahrilas; Hyon C Kim; John E Pandolfino
Journal:  Best Pract Res Clin Gastroenterol       Date:  2008       Impact factor: 3.043

9.  Relationship of overweight to hiatus hernia and reflux oesophagitis.

Authors:  G Stene-Larsen; R Weberg; I Frøyshov Larsen; O Bjørtuft; B Hoel; A Berstad
Journal:  Scand J Gastroenterol       Date:  1988-05       Impact factor: 2.423

10.  Hypercalcemia associated with acute kidney injury and metabolic alkalosis.

Authors:  Jong Hyeok Jeong; Eun Hui Bae
Journal:  Electrolyte Blood Press       Date:  2010-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.